Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans – man and his best friend share more than companionship
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
The pathophysiological similarities shared by many forms of human and canine disease, combined with the sophisticated genomic resources now available for the dog, have placed ‘man’s best friend’ in a position of high visibility as a model system for a variety of biomedical concerns, including cancer. The importance of nonrandom cytogenetic abnormalities in human leukemia and lymphoma was recognized over 40 years ago, but the mechanisms of genome reorganization remain incompletely understood. The development of molecular cytogenetics, using fluorescence in situ hybridization (FISH) technology, has played a significant role in our understanding of cancer biology by providing a means for ‘interrogating’ tumor cells for a variety of gross genetic changes in the form of either numerical or structural chromosome aberrations. Here, we have identified cytogenetic abnormalities in naturally occurring canine hematopoietic tumors that are evolutionarily conserved compared with those that are considered characteristic of the corresponding human condition. These data suggest that humans and dogs share an ancestrally retained pathogenetic basis for cancer and that cytogenetic evaluation of canine tumors may provide greater insight into the biology of tumorigenesis.
- Breen M, Thomas R, Binns MM, Carter NP, Langford CF (1999) Reciprocal chromosome painting reveals detailed regions of conserved synteny between the karyotypes of the domestic dog (Canis familiaris) and human. Genomics 61: 145–155. CrossRef
- Breen M, Jouquand S, Renier C et al. (2001) Chromosome-specific single-locus FISH probes allow anchorage of an 1800-marker integrated radiation-hybrid/linkage map of the domestic dog genome to all chromosomes. Genome Res 11: 1784–1795. CrossRef
- Breen M, Hitte C, Lorentzen TD et al. (2004) An integrated 4249 marker FISH/RH map of the canine genome. BMC Genomics 5: 65. CrossRef
- Burnett RC, Vernau W, Modiano JF et al. (2003) Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol 40: 32–41. CrossRef
- Calin GA, Croce CM (2006) Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Semin Oncol 33: 167–173. CrossRef
- Cimmino A, Calin GA, Fabbri M et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102: 13944–13949. CrossRef
- Dickerson EB, Fosmire S, Padilla ML, Modiano JF, Helfand SC (2002) Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer. J Immunother 25: 36–45. CrossRef
- Dohner H, Stilgenbauer S, Benner A et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910–1916. CrossRef
- Fernandes PJ, Modiano JF, Wojcieszyn J et al. (2002) Use of the Cell-Dyn 3500 to predict leukemic cell lineage in peripheral blood of dogs and cats. Vet Clin Pathol 31: 167–182. CrossRef
- Ferry JA (2006) Burkitt’s lymphoma: clinicopathologic features and differential diagnosis. Oncologist 11: 375–383. CrossRef
- Haigh S, Cuthbert G (2004) Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia. Cancer Genet Cytogenet 155: 132–137. CrossRef
- Hecht JL, Aster JC (2000) Molecular biology of Burkitt’s lymphoma. J Clin Oncol 18: 3707–3721.
- Jubala CM, Wojcieszyn JW, Valli VE et al. (2005) CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma. Vet Pathol 42: 468–476. CrossRef
- Kirkness E, Bafna V, Halpern A et al. (2003) The dog genome: survey sequencing and comparative analysis. Science 301: 1898–1903. CrossRef
- Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M (2003) Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med 138: 819–830.
- Lander ES, Linton LM, Birren B et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860–921. CrossRef
- Lindblad-Toh K, Wade CM, Mikkelsen TS et al. (2005) Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438: 803–819. CrossRef
- Modiano J, Breen M, Avery A, London C (2005) Breed specific canine lymphoproliferative diseases. In: Ostrander EA, Giger U, Lindblad-Toh K, eds. The Dog and its Genome. Cold Spring Harbor, NY: CSH Press.
- Murphy WJ, Larkin DM, Everts-Van Der Wind A et al. (2005) Dynamics of mammalian chromosome evolution inferred from multispecies comparative maps. Science 309: 613–617. CrossRef
- O’Brien SJ, Eisenberg JF, Miyamoto M et al. (1999) Genome maps 10. Comparative genomics. Mammalian radiations. Wall chart. Science 286: 463–478. CrossRef
- Ostrander EA (2007) Genetics and the shape of dogs. Am Sci 95: 406–413.
- Parker H, Kim L, Sutter N et al. (2004) Genetic structure of the purebred domestic dog. Science 304: 1160–1164. CrossRef
- Ritt MG, Mayor J, Wojcieszyn J et al. (2000) Sustained nuclear localization of p21/WAF-1 upon growth arrest induced by contact inhibition. Cancer Lett 158: 73–84. CrossRef
- Rowley JD (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290–293. CrossRef
- Schlegelberger B, Himmler A, Godde E et al. (1994) Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 83: 505–511.
- Sutter NB, Eberle MA, Parker HG et al. (2004) Extensive and breed-specific linkage disequilibrium in Canis familiaris. Genome Res 14: 2388–2396. CrossRef
- Taub R, Moulding C, Battey J et al. (1984) Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells. Cell 36: 339–348. CrossRef
- Thomas R, Bridge W, Benke K, Breen M (2003a) Isolation and chromosomal assignment of canine genomic BAC clones representing 25 cancer related canine genes. Cytogenet Genome Res 102: 249–253. CrossRef
- Thomas R, Fiegler H, Ostrander EA et al. (2003b) A canine cancer-gene microarray for CGH analysis of tumors. Cytogenet Genome Res 102: 254–260. CrossRef
- Thomas R, Smith KC, Ostrander EA, Galibert F, Breen M (2003c) Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. Br J Cancer 89: 1530–1537. CrossRef
- Valli VE, Jacobs RM, Parodi AL, Vernau W, Moore PF (2002) Classification of Hematopoietic Tumors of Domestic Animals. Second Series. Washington, DC: AFIP– American Registry of Pathology.
- Wertheim JA, Miller JP, Xu L, He Y, Pear WS (2002) The biology of chronic myelogenous leukemia:mouse models and cell adhesion. Oncogene 21: 8612–8628. CrossRef
- Withrow SJ, Vail D (2006) Small Animal Clinical Oncology. Philadelphia: WB Saunders.
- Yang F, O’Brien PC, Milne BS et al. (1999) A complete comparative chromosome map for the dog, red fox, and human and its integration with canine genetic maps. Genomics 62: 189–202. CrossRef
- Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans – man and his best friend share more than companionship
Volume 16, Issue 1 , pp 145-154
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street, Raleigh, NC, 27606, USA
- 2. Center for Comparative Medicine and Translational Research, North Carolina State University, Raleigh, NC, USA
- 3. Integrated Department of Immunology and Cancer Center, School of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
- 4. Department of Veterinary Clinical Sciences – College of Veterinary Medicine, and Cancer Center, University of Minnesota, St Paul, MN, 55108, USA